Omega-3 Fatty Acids and Cardiovascular Disease
Publisher: Agency for Healthcare Research and Quality 2016
Number of pages: 1252
There have been hundreds of observational studies and clinical trials conducted to evaluate the effect of omega-3 fatty acids (n-3 FA) on CV disease (CVD) and its risk factors and intermediate markers. The n-3 FA are a group of long-chain and very-long-chain polyunsaturated fatty acids (PUFA) that are substrates for the synthesis of eicosanoids and are important components of cell membranes that impact fluidity.
Home page url
Download or read it online for free here:
- Agency for Healthcare Research and Quality
There are two generally accepted strategies for managing atrial fibrillation (AF): rate control and rhythm control. However, within each strategic approach there are a large number of potential pharmacological and nonpharmacological therapies...
by Jeffrey Shuhaiber - InTech
The assist devices will continue adding a large number of years of life to humans and empower the medical society to optimize heart failure therapy. This book reflects the contemporary research from a multitude of different experts in the field.
- Royal College of Physicians
The guideline covers aspects of diagnosis and the management of atrial fibrillation (AF) in a number of different circumstances. It covers paroxysmal, persistent and permanent AF, and considers AF developing after surgical procedures.
by Patrizio Lancellotti, et al. - European Heart Journal
In this document, we describe the practical applications of echocardiography in patients with acute cardiac conditions, in particular with acute chest pain, acute heart failure, suspected cardiac tamponade, complications of myo-cardial infarction ...